Eli Lilly's soaring stock price has sparked 2026 split speculation. Here's what a potential LLY split could mean and what investors should consider now.

Eli Lilly's stock is a bit expensive, even with a bit of a decline this year.

Eli Lilly has been a growth beast in recent years, but its valuation has gotten fairly high along the way.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The company still has a robust business that is delivering excellent results and ...

Investors generally don't turn to pharmaceutical stocks with expectations of high growth in a short period of time. Instead, they scoop up these players for their promise of steady gains over the ...

With short-term returns turning negative, analysts are reassessing Lilly's high valuation, reminding the market that even ...

Eli Lilly (NYSE: LLY) is close to doing something no other pharmaceutical company has ever done: reaching $1 trillion in market value. The company briefly touched that level in November but has since ...

Drugmaker Eli Lilly reached a $1 trillion market capitalization, the first health-care company in the world to join the exclusive club dominated by tech firms. The pharmaceutical giant's stock has ...